ABL-25503-53326
5 vaccinations
5 coded responses
55 check-ins
5 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 779 / TX
- Registered
- 2021-02-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-20
Dose 1 — Moderna
-
2021-02-21
Registered in v-safe
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-27
- 2021-03-20
-
2021-03-24
Dose 2 — Moderna
- 2021-03-27
-
2021-03-28
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-22
- 2021-04-28
- 2021-05-05
- 2021-06-23
- 2021-09-22
-
2021-10-27
Dose 3 — Moderna
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-11
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2022-01-26
- 2022-04-27
-
2022-05-10
Dose 4 — Moderna
-
2022-05-18
Survey response — day 7, dose 4MedDRA: Injection site pruritus, Pain in extremity — Feeling: GoodFree text: For about five days after receiving fourth shot the injection spot itched. No other symptoms except perhaps a little soreness on arm.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-24
- 2022-05-31
- 2022-06-07
- 2022-06-14
- 2022-06-21
- 2022-08-11
-
2022-09-27
Dose 5 — Pfizer-BioNTech
-
2022-09-27
Survey response — day 0, dose 5MedDRA: No adverse event — Feeling: Good · Site: ItchingFree text:MedDRA releases: 2024-11 · check-in free text available
- 2022-09-28
-
2022-09-29
Survey response — days 1–6 daily, dose 5MedDRA: Injection site erythema, Injection site swelling — Feeling: Good · Site: ItchingFree text: Noticed that where is a slightly elevated red circle about 1-1/2" in diameter around the injection site.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-08
-
2022-12-27
Survey response — 3 months, dose 5MedDRA: Cough, Herpes zoster, Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Had a cold with persistent cough that lasted almost three week. Shortly after those symptoms went away I came down with Shingles on the left side of my face.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-27
Report sent to call center — 3 months, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-28
-
2022-12-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-20 | Moderna | |
| 2 | 2021-03-24 | Moderna | |
| 3 | 2021-10-27 | Moderna | No |
| 4 | 2022-05-10 | Moderna | No |
| 5 | 2022-09-27 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): None
Release 11 — day 7, dose 4
Systemic reaction (other): For about five days after receiving fourth shot the injection spot itched. No other symptoms except perhaps a little soreness on arm.
Release 12 — day 0, dose 5
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Noticed that where is a slightly elevated red circle about 1-1/2" in diameter around the injection site.
Release 12 — 3 months, dose 5
Symptoms: Had a cold with persistent cough that lasted almost three week. Shortly after those symptoms went away I came down with Shingles on the left side of my face.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Herpes zoster | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site pruritus | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release